Hanning, Uta http://orcid.org/0000-0002-7543-8555
Bechstein, Matthias http://orcid.org/0000-0002-5652-7499
Kaesmacher, Johannes
Boulouis, Grégoire
Chapot, René
Andersson, Tommy
Boccardi, Edoardo
Psychogios, Marios
Cognard, Christophe
de Dios Lascuevas, Marta
Rodrigues, Marta
Rodriguez Caamaño, Isabel
Gargalas, Sergios
Simonato, Davide
Zupancic, Vedran
Daller, Cornelia
Meyer, Lukas
Broocks, Gabriel
Guerreiro, Helena
Fiehler, Jens
Martínez-Galdamez, Mario
Kalousek, Vladimir
Funding for this research was provided by:
Education Grant from Cerenovus
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 18 May 2022
Accepted: 20 June 2022
First Online: 13 July 2022
Conflict of interest
: T. Andersson: consultant for Anaconda, Cerenovus/Neuravi, Rapid Medical and Stryker. Holds equity in Ceroflo. J. Fiehler: grants or contracts from any entity: Acandis, Cerenovus, Medtronic, Microvention, Stryker, all research funding, unrelated; consulting fees: Acandis, Cerenovus, Medtronic, Microvention, Stryker, Penumbra, Phenox; Participation on a data safety monitoring board or advisory board: Stryker; leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: ESMINT president(unpaid); stock or stock options: Tegus Medical. U. Hanning, M. Bechstein, J. Kaesmacher, G. Boulouis, R. Chapot, E. Boccardi, M. Psychogios, C. Cognard, M. de Dios Lascuevas, M. Rodrigues, I. Rodriguez Caamaño, S. Gargalas, D. Simonato, V. Zupancic, C. Daller, L. Meyer, G. Broocks, H. Guerreiro, M. Martínez-Galdamez, and V. Kalousek declare that they have no competing interests.